124 related articles for article (PubMed ID: 1545089)
1. The effect of inhaled gallopamil, a potent calcium channel blocker, on the late-phase response in subjects with allergic asthma.
Hoppe M; Harman E; Hendeles L
J Allergy Clin Immunol; 1992 Mar; 89(3):688-95. PubMed ID: 1545089
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
Twentyman OP; Finnerty JP; Holgate ST
Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
[TBL] [Abstract][Full Text] [Related]
3. Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise.
Massey KL; Hill M; Harman E; Rutledge DR; Ahrens R; Hendeles L
J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):912-8. PubMed ID: 3286722
[TBL] [Abstract][Full Text] [Related]
4. Duration of protection of calcium channel blockers against exercise-induced bronchospasm: comparison of oral diltiazem and inhaled gallopamil.
Massey KL; Harman E; Hendeles L
Eur J Clin Pharmacol; 1988; 34(6):555-9. PubMed ID: 3169109
[TBL] [Abstract][Full Text] [Related]
5. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
6. Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients.
Taylor DA; Harris JG; O'Connor BJ
Clin Exp Allergy; 2000 Jan; 30(1):56-63. PubMed ID: 10606931
[TBL] [Abstract][Full Text] [Related]
7. Changes in bronchial responsiveness to histamine at intervals after allergen challenge.
Cockcroft DW; Murdock KY
Thorax; 1987 Apr; 42(4):302-8. PubMed ID: 3616989
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen dioxide exposure enhances asthmatic reaction to inhaled allergen in subjects with asthma.
Strand V; Rak S; Svartengren M; Bylin G
Am J Respir Crit Care Med; 1997 Mar; 155(3):881-7. PubMed ID: 9117021
[TBL] [Abstract][Full Text] [Related]
9. Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler.
Hendeles L; Harman E; Huang D; O'Brien R; Blake K; Delafuente J
J Allergy Clin Immunol; 1995 Feb; 95(2):505-14. PubMed ID: 7852666
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhaled prostaglandin E2 on allergen-induced asthma.
Pavord ID; Wong CS; Williams J; Tattersfield AE
Am Rev Respir Dis; 1993 Jul; 148(1):87-90. PubMed ID: 8317820
[TBL] [Abstract][Full Text] [Related]
12. Circulating histamine and neutrophil chemotactic activity during allergen-induced asthma: the effect of inhaled antihistamines and anti-allergic compounds.
Morgan DJ; Moodley I; Cundell DR; Sheinman BD; Smart W; Davies RJ
Clin Sci (Lond); 1985 Jul; 69(1):63-9. PubMed ID: 2866059
[TBL] [Abstract][Full Text] [Related]
13. Effect of allergen challenge on airway responsiveness to histamine and sodium metabisulphite in mild asthma.
Evans DJ; Coulby LJ; O'Connor BJ
Thorax; 1996 Dec; 51(12):1185-91. PubMed ID: 8994513
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.
O'Shaughnessy KM; Wellings R; Gillies B; Fuller RW
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1472-6. PubMed ID: 8389108
[TBL] [Abstract][Full Text] [Related]
15. Allergen bronchoprovocation of patients with mild allergic asthma after ozone exposure.
Ball BA; Folinsbee LJ; Peden DB; Kehrl HR
J Allergy Clin Immunol; 1996 Sep; 98(3):563-72. PubMed ID: 8828534
[TBL] [Abstract][Full Text] [Related]
16. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
[TBL] [Abstract][Full Text] [Related]
17. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
Crimi N; Polosa R; Pulvirenti G; Magrì S; Santonocito G; Prosperini G; Mastruzzo C; Mistretta A
Thorax; 1995 May; 50(5):505-10. PubMed ID: 7597662
[TBL] [Abstract][Full Text] [Related]
18. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
[TBL] [Abstract][Full Text] [Related]
19. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C
Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions.
Bianco S; Pieroni MG; Refini RM; Rottoli L; Sestini P
N Engl J Med; 1989 Oct; 321(16):1069-73. PubMed ID: 2797066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
